What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His main research concerns Pulmonary hypertension, Internal medicine, Endocrinology, Lung and Hypoxia.
His Pulmonary hypertension research integrates issues from Respiratory disease, Anesthesia, Pathology, Sildenafil and Muscle hypertrophy.
His study in Internal medicine is interdisciplinary in nature, drawing from both Pharmacology and Cardiology.
His Endocrinology research is multidisciplinary, relying on both Ex vivo and Imatinib mesylate.
He has researched Lung in several fields, including Vascular remodelling in the embryo and Pulmonary artery.
His Hypoxia research incorporates themes from Reactive oxygen species, Biochemistry, Mitochondrion and Cell biology.
His most cited work include:
- Reversal of experimental pulmonary hypertension by PDGF inhibition. (874 citations)
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial (668 citations)
- Cellular and molecular basis of pulmonary arterial hypertension. (613 citations)
What are the main themes of his work throughout his whole career to date?
Norbert Weissmann spends much of his time researching Pulmonary hypertension, Internal medicine, Lung, Hypoxia and Cardiology.
The various areas that he examines in his Pulmonary hypertension study include Respiratory disease, Pathology, Pulmonary artery, Muscle hypertrophy and Pharmacology.
His Internal medicine study frequently intersects with other fields, such as Endocrinology.
In his research on the topic of Lung, Lung injury is strongly related with Immunology.
His work deals with themes such as Cancer research, Downregulation and upregulation, Right ventricular hypertrophy and Cell biology, which intersect with Hypoxia.
The concepts of his Hypoxic pulmonary vasoconstriction study are interwoven with issues in Reactive oxygen species and Respiratory system.
He most often published in these fields:
- Pulmonary hypertension (45.47%)
- Internal medicine (40.62%)
- Lung (24.06%)
What were the highlights of his more recent work (between 2017-2021)?
- Pulmonary hypertension (45.47%)
- Internal medicine (40.62%)
- Hypoxia (23.84%)
In recent papers he was focusing on the following fields of study:
Pulmonary hypertension, Internal medicine, Hypoxia, Lung and Cardiology are his primary areas of study.
Norbert Weissmann has included themes like Ventricle, COPD, Disease, Pulmonary artery and Pharmacology in his Pulmonary hypertension study.
His Internal medicine research includes themes of Gastroenterology and Endocrinology.
Norbert Weissmann combines subjects such as Rat model and Pathology with his study of Hypoxia.
He interconnects Inflammation, Cancer research and Intracellular in the investigation of issues within Lung.
His study in the fields of Heart failure and Cardiac function curve under the domain of Cardiology overlaps with other disciplines such as Pressure overload.
Between 2017 and 2021, his most popular works were:
- Pulmonary hypertension in chronic lung disease and hypoxia. (140 citations)
- Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension (25 citations)
- A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension. (23 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His scientific interests lie mostly in Pulmonary hypertension, Hypoxia, Inflammation, Pharmacology and Cancer research.
The Pulmonary hypertension study combines topics in areas such as Pulmonary artery and Pathology.
His Hypoxia research includes elements of Cytochrome c oxidase, COX4I2 and Respiratory center.
His study in Inflammation is interdisciplinary in nature, drawing from both Wasting, Immune system and Pathogenesis.
His Pharmacology research incorporates elements of Immunohistochemistry, In vitro and Downregulation and upregulation.
His studies in Cancer research integrate themes in fields like Apoptosis, Retinoblastoma protein, Signal transduction and Lung.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
